Oligonucleotides: evolution and innovation

AA Mohammed, D AlShaer, O Al Musaimi - Medicinal Chemistry Research, 2024 - Springer
Oligonucleotides, comprising single or double strands of RNA or DNA, are vital chemical
compounds used in various laboratory and clinical applications. They represent a significant …

Oligonucleotide technologies: synthesis, production, regulations and applications

E Uhlmann - Expert Opinion on Biological Therapy, 2001 - Taylor & Francis
The two-day meeting 'Oligonucleotide technologies', organised by IBC Global Conferences
Limited and chaired by M Gait (Medical Research Council, UK), was the first event of this …

DNA analogues modified at the nonlinking positions of phosphorus

P Kumar, MH Caruthers - Accounts of Chemical Research, 2020 - ACS Publications
Conspectus Chemically modified oligonucleotides are being developed as a new class of
medicines for curing conditions that previously remained untreatable. Three primary classes …

Oligonucleotide therapeutics: from discovery and development to patentability

L Moumné, AC Marie, N Crouvezier - Pharmaceutics, 2022 - mdpi.com
Following the first proof of concept of using small nucleic acids to modulate gene
expression, a long period of maturation led, at the end of the last century, to the first …

[HTML][HTML] A short history of oligonucleotide synthesis

R Hogrefe, T BioTechnologies - Trilink Biotechnologies, 2014 - trilinkbiotech.com
In order to offer an exhaustive report on the history of oligonucleotide synthesis, it would be
necessary to examine the history of modern biotechnology, for the two are tightly interwoven …

Recent advances in scale-up of modified oligodeoxynucleotides.

Z Zhang, JY Tang - Current opinion in drug discovery & …, 1998 - europepmc.org
Progress in the field of oligonucleotide therapeutics has created the need for scale-up of
oligonucleotide synthesis from milligram to multikilogram and higher. The synthesis and …

Nucleic Acids Research and Nucleic Acid Therapeutics

BL Stoddard, A Khvorova, DR Corey… - Nucleic acids …, 2018 - academic.oup.com
Over the past several decades, the concept of using molecules composed partially or wholly
of nucleic acids as therapeutic moieties, and the modification of such molecules via synthetic …

Oligonucleotide therapeutics and their chemical modification strategies for clinical applications

H Kim, S Kim, D Lee, D Lee, J Yoon, H Lee - Journal of Pharmaceutical …, 2024 - Springer
Background Oligonucleotide therapeutics have emerged as a promising and dynamic class
of pharmaceutical agents with remarkable potential for treating a wide spectrum of genetic …

Oligonucleotide therapeutics

JS Cohen - Trends in biotechnology, 1992 - Elsevier
Recent studies have focused on the ability of oligonucleotides to affect the genetic
processes of many organisms, including viruses. Hence, oligonucleotides may represent a …

[HTML][HTML] Manual and automated synthesis of modified oligonucleotides on core–shell solid supports

LM Menéndez-Méndez, C Fàbrega, A Aviñó, R Eritja… - Results in …, 2024 - Elsevier
A critical step in the manufacturing of oligonucleotides is the selection of ideal solid
supports. Herein, we evaluate a hybrid core–shell solid support made of polystyrene and …